Literature DB >> 17021222

Culture-independent analysis of indomethacin-induced alterations in the rat gastrointestinal microbiota.

Andrew B Dalby1, Daniel N Frank, Allison L St Amand, Alison M Bendele, Norman R Pace.   

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed for a variety of inflammatory conditions; however, the benefits of this class of drugs are accompanied by deleterious side effects, most commonly gastric irritation and ulceration. NSAID-induced ulceration is thought to be exacerbated by intestinal microbiota, but previous studies have not identified specific microbes that contribute to these adverse effects. In this study, we conducted a culture-independent analysis of approximately 1,400 bacterial small-subunit rRNA genes associated with the small intestines and mesenteric lymph nodes of rats treated with the NSAID indomethacin. This is the first molecular analysis of the microbiota of the rat small intestine. A comparison of clone libraries and species-specific quantitative PCR results from rats treated with indomethacin and untreated rats revealed that organisms closely related to Enterococcus faecalis were heavily enriched in the small intestine and mesenteric lymph nodes of the treated rats. These data suggest that treatment of NSAID-induced ulceration may be facilitated by addressing the microbiological imbalances.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17021222      PMCID: PMC1610281          DOI: 10.1128/AEM.00378-06

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  43 in total

1.  Culture-independent molecular analysis of microbial constituents of the healthy human outer ear.

Authors:  Daniel N Frank; George B Spiegelman; William Davis; Eileen Wagner; Eric Lyons; Norman R Pace
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

Review 2.  Mechanisms underlying intestinal injury induced by anti-inflammatory COX inhibitors.

Authors:  Brendan J R Whittle
Journal:  Eur J Pharmacol       Date:  2004-10-01       Impact factor: 4.432

3.  Unexpected diversity and complexity of the Guerrero Negro hypersaline microbial mat.

Authors:  Ruth E Ley; J Kirk Harris; Joshua Wilcox; John R Spear; Scott R Miller; Brad M Bebout; Julia A Maresca; Donald A Bryant; Mitchell L Sogin; Norman R Pace
Journal:  Appl Environ Microbiol       Date:  2006-05       Impact factor: 4.792

4.  Molecular-phylogenetic analyses of human gastrointestinal microbiota.

Authors:  D N Frank; N R Pace
Journal:  Curr Opin Gastroenterol       Date:  2001-01       Impact factor: 3.287

5.  Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.

Authors:  Julia Hippisley-Cox; Carol Coupland; Richard Logan
Journal:  BMJ       Date:  2005-12-03

6.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors:  F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272

7.  Differential roles of segmented filamentous bacteria and clostridia in development of the intestinal immune system.

Authors:  Y Umesaki; H Setoyama; S Matsumoto; A Imaoka; K Itoh
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

8.  Resistance of germfree rats to indomethacin-induced intestinal lesions.

Authors:  A Robert; T Asano
Journal:  Prostaglandins       Date:  1977-08

9.  Mechanisms of acute and chronic intestinal inflammation induced by indomethacin.

Authors:  T Yamada; E Deitch; R D Specian; M A Perry; R B Sartor; M B Grisham
Journal:  Inflammation       Date:  1993-12       Impact factor: 4.092

10.  Obesity alters gut microbial ecology.

Authors:  Ruth E Ley; Fredrik Bäckhed; Peter Turnbaugh; Catherine A Lozupone; Robin D Knight; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-20       Impact factor: 11.205

View more
  28 in total

Review 1.  Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.

Authors:  John L Wallace
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

2.  Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling.

Authors:  Kenichi Yoshikawa; Chie Kurihara; Hirotaka Furuhashi; Takeshi Takajo; Koji Maruta; Yuichi Yasutake; Hirokazu Sato; Kazuyuki Narimatsu; Yoshikiyo Okada; Masaaki Higashiyama; Chikako Watanabe; Shunsuke Komoto; Kengo Tomita; Shigeaki Nagao; Soichiro Miura; Hisao Tajiri; Ryota Hokari
Journal:  J Gastroenterol       Date:  2016-04-13       Impact factor: 7.527

3.  Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle.

Authors:  Jan Bures; David Smajs; Jaroslav Kvetina; Miroslav Förstl; Jan Smarda; Darina Kohoutova; Martin Kunes; Jiri Cyrany; Ilja Tacheci; Stanislav Rejchrt; Jirina Lesna; Viktor Vorisek; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

Review 4.  Mucin dynamics and enteric pathogens.

Authors:  Michael A McGuckin; Sara K Lindén; Philip Sutton; Timothy H Florin
Journal:  Nat Rev Microbiol       Date:  2011-04       Impact factor: 60.633

Review 5.  The microbiome in wound repair and tissue fibrosis.

Authors:  Brittan S Scales; Gary B Huffnagle
Journal:  J Pathol       Date:  2012-11-29       Impact factor: 7.996

6.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.

Authors:  Daniel N Frank; Allison L St Amand; Robert A Feldman; Edgar C Boedeker; Noam Harpaz; Norman R Pace
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-15       Impact factor: 11.205

7.  Opportunistic pathogens enriched in showerhead biofilms.

Authors:  Leah M Feazel; Laura K Baumgartner; Kristen L Peterson; Daniel N Frank; J Kirk Harris; Norman R Pace
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-14       Impact factor: 11.205

8.  The microbiota-derived metabolite indole decreases mucosal inflammation and injury in a murine model of NSAID enteropathy.

Authors:  Canaan M Whitfield-Cargile; Noah D Cohen; Robert S Chapkin; Brad R Weeks; Laurie A Davidson; Jennifer S Goldsby; Carrie L Hunt; Shelby H Steinmeyer; Rani Menon; Jan S Suchodolski; Arul Jayaraman; Robert C Alaniz
Journal:  Gut Microbes       Date:  2016-03-23

9.  Host responses to intestinal microbial antigens in gluten-sensitive mice.

Authors:  Jane M Natividad; Xianxi Huang; Emma Slack; Jennifer Jury; Yolanda Sanz; Chella David; Emmanuel Denou; Pinchang Yang; Joseph Murray; Kathy D McCoy; Elena F Verdú
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

10.  The Nonsteroidal Anti-Inflammatory Drug Ketorolac Alters the Small Intestinal Microbiota and Bile Acids Without Inducing Intestinal Damage or Delaying Peristalsis in the Rat.

Authors:  Barbara Hutka; Bernadette Lázár; András S Tóth; Bence Ágg; Szilvia B László; Nóra Makra; Balázs Ligeti; Bálint Scheich; Kornél Király; Mahmoud Al-Khrasani; Dóra Szabó; Péter Ferdinandy; Klára Gyires; Zoltán S Zádori
Journal:  Front Pharmacol       Date:  2021-06-04       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.